Other studies have reported a higher DM prevalence in severe cases of COVID-19 when compared to mild cases (14.3 vs 5.0%, p= 0 009), as well as an increased mortality risk and an increased case fatality rate in patients with DM (~ 3x, Fig. 1), in comparison to persons without DM (7.3 vs 2.3%, respectively), indicating the amplified risk to patients with DM.